Linkedin X-twitter
Search

+44 (0)20 7722 1221

[email protected]

VIEW OPPORTUNITIES

SHARE

Demant agrees to sell Oticon Medical to Impilo, completing hearing implants exit

Demant has agreed to sell its Oticon Medical unit to Nordic investor Impilo for up to DKK 600m, with DKK 325m paid at closing and the remainder as milestones. The deal finalises Demant’s exit from hearing implants, with closure expected by Q1 2026.
Read the full article.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.